Copyright © 2007, European Society of Cardiology
Downregulation of CuZn-superoxide dismutase contributes to β-adrenergic receptor-mediated oxidative stress in the heart
aLouisville VAMC and Institute of Molecular Cardiology, Department of Medicine, University of Louisville, Louisville, KY, United States
bMedicine/Cardiology, University of Texas Health Science Center, San Antonio, TX, United States
* Corresponding author. Medicine/Cardiology, University of Louisville, ACB, 3rd Floor, 550 South Jackson Street, Louisville, KY 40202, United States. Tel.: +1 502 852 7959; fax: +1 502 852 7147. Email address: sprabhu{at}louisville.edu
Objective: Sustained β-adrenergic receptor (β-AR) activation augments oxidative stress in the heart; whether alterations in antioxidant enzymes contribute to this effect is unknown.
Methods and results: Adult male Wistar rats were implanted with osmotic minipumps to infuse either L-isoproterenol (ISO, 25 µg/kg/h) or saline (SAL). After 7-days, ISO-treated hearts exhibited significant (p<0.005): 1) concentric hypertrophy and augmentation of systolic function, 2) reductions of end-systolic wall stress, and 3) augmentation of oxidative stress, with a 
3-fold increase in 4-hydroxy-2-nonenal-and malondialdehyde-protein adducts. ISO-treated hearts also exhibited significant (p<0.01) reductions of CuZn-superoxide dismutase (SOD) enzyme activity (30%), protein (40%), and mRNA (60%), without changes in Mn–SOD, catalase, or glutathione peroxidase. Elk-1 and YinYang1 (YY1) are transcription factors that positively and negatively regulate CuZn–SOD expression, respectively. ISO-treated hearts exhibited a 3-fold increase in YY1 and a 2-fold reduction in Elk-1 DNA binding activity, strongly favoring CuZn–SOD gene repression. In isolated cardiomyocytes, sustained (24 h) ISO stimulation significantly (p<0.01) increased reactive oxygen species (ROS), an effect blocked by CGP20712A, a β1-AR antagonist, but not by ICI118,551, a β2-AR antagonist. CuZn–SOD downregulation paralleled the increase in ROS, and were similarly blocked by β1- but not β2-AR blockade. There were no changes in CuZn–SOD mRNA stability or myocyte size with ISO treatment. However, nuclear run-on revealed a 40% reduction in CuZn–SOD mRNA expression (p<0.01), consistent with transcriptional repression. ISO also depressed total cellular antioxidant capacity, reduced glutathione (GSH) levels, and the GSH:GSSG ratio. Moreover, CuZn–SOD siRNA transfection of H9c2 cardiomyocytes to suppress CuZn–SOD protein by 40–50% (analogous to the in vivo changes) induced cellular apoptosis.
Conclusions: Sustained β-AR stimulation transcriptionally downregulates CuZn–SOD in myocardium via the β1-AR, thereby contributing to β-AR-mediated oxidative stress.
KEYWORDS β-adrenergic receptor; Oxidative stress; Copper-zinc superoxide dismutase
Time for primary review 29 days
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  T. Hamid, Y. Gu, R. V. Ortines, C. Bhattacharya, G. Wang, Y.-T. Xuan, and S. D. Prabhu Divergent Tumor Necrosis Factor Receptor-Related Remodeling Responses in Heart Failure: Role of Nuclear Factor-{kappa}B and Inflammatory Activation Circulation, March 17, 2009; 119(10): 1386 - 1397. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Tapryal, C. Mukhopadhyay, D. Das, P. L. Fox, and C. K. Mukhopadhyay Reactive Oxygen Species Regulate Ceruloplasmin by a Novel mRNA Decay Mechanism Involving Its 3'-Untranslated Region: IMPLICATIONS IN NEURODEGENERATIVE DISEASES J. Biol. Chem., January 16, 2009; 284(3): 1873 - 1883. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. K. Soukhova-O'Hare, R. V. Ortines, Y. Gu, A. D. Nozdrachev, S. D. Prabhu, and D. Gozal Postnatal Intermittent Hypoxia and Developmental Programming of Hypertension in Spontaneously Hypertensive Rats: The Role of Reactive Oxygen Species and L-Ca2+ Channels Hypertension, July 1, 2008; 52(1): 156 - 162. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Murtaza, H.-X. Wang, X. Feng, N. Alenina, M. Bader, B. S. Prabhakar, and P.-F. Li Down-regulation of Catalase and Oxidative Modification of Protein Kinase CK2 Lead to the Failure of Apoptosis Repressor with Caspase Recruitment Domain to Inhibit Cardiomyocyte Hypertrophy J. Biol. Chem., March 7, 2008; 283(10): 5996 - 6004. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Luo, B. G. Hill, Y. Gu, J. Cai, S. Srivastava, A. Bhatnagar, and S. D. Prabhu Mechanisms of acrolein-induced myocardial dysfunction: implications for environmental and endogenous aldehyde exposure Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3673 - H3684. [Abstract] [Full Text] [PDF]
|
|